Notification regarding Performance Rights

Capital Change Notice




Section 1: Issuer information
Name of issuer EBOS Group Limited
NZX ticker code EBO
Class of financial product Performance Rights representing an
entitlement to ordinary shares pursuant to the
EBOS Group Limited Performance Rights
Plan (Plan).
ISIN (If unknown, check on NZX website) Not applicable – the Performance Rights will
not be listed on NZX or ASX.
Currency Not applicable.
Section 2: Capital change details
Number issued/acquired/redeemed 192,753 Performance Rights
Nominal value (if any) Not applicable.
Issue/acquisition/redemption price per security Not applicable.
Nature of the payment (for example, cash or
other consideration)
Not applicable.
Amount paid up (if not in full) Not applicable.
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1

53.8% of Performance Rights on issue.
For an issue of Convertible Financial Products
or Options, the principal terms of Conversion
(for example the Conversion price and
Conversion date and the ranking of the
Financial Product in relation to other Classes of
Financial Product) or the Option (for example,
the exercise price and exercise date)
Vesting of the Performance Rights is subject
to the satisfaction of certain conditions
relating to EBOS Group Limited financial
performance and the continued employment
of the holder of the Performance Rights
(Performance Conditions).

The Performance Conditions will be tested
after the end of the performance period,
being 1 July 2019 to 30 June 2022.

If the Performance Rights vest, the holder will
be entitled to one fully paid ordinary share in
EBOS Group Limited for each Performance
Right or an equivalent amount in cash or a
combination of both (as determined by the
Board). Any fully paid ordinary shares
issued following vesting will rank equally with
existing fully paid ordinary shares.


1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

The Performance Rights have no dividend
entitlement prior to vesting.

There is no amount payable by the
Performance Rights holders either on grant
or exercise of the Performance Rights.
Reason for issue/acquisition/redemption and
specific authority for
issue/acquisition/redemption/ (the reason for
change must be identified here)
Issue of Performance Rights under the Plan.
Total number of Financial Products of the Class
after the
issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total number
of Financial Products of the Class held as
Treasury Stock after the
issue/acquisition/redemption.
358,803 Performance Rights.
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
Not applicable.
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
Directors’ resolution.
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
Please see above.
Date of issue/acquisition/redemption
2
9 September 2019
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Janelle Cain
Contact person for this announcement Janelle Cain
Contact phone number +61 3 9918 5555
Contact email address janelle.cain@ebosgroup.com
Date of release through MAP

9 September 2019




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).

---

EBOS Group Limited. NZBN 9429031998840
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia.
Phone: +61 3 9918 5555, Fax: +61 3 9918 5588.
www.ebosgroup.com



9 September 2019
NZX/ASX Code: EBO

Lapse of Performance Rights


EBOS Group Limited today announces the lapse of 14,250 performance rights issued on 30 October
2018.


Janelle Cain
General Counsel
EBOS Group Limited


For further information, please contact:
Mark Connell
Investor Relations Manager
EBOS Group Limited
+61 402 995 519

---

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 1
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B

New issue announcement,
application for quotation of additional securities
and agreement

Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13


Name of entity
EBOS Group Limited

ABN
N/A

We (the entity) give ASX the following information.


Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).

1
+
Class of
+
securities issued or to
be issued

1. Issue of Performance Rights (unquoted)
2. Lapse of Performance Rights issued on 30
October 2018


2 Number of
+
securities issued or to
be issued (if known) or maximum
number which may be issued

1. 192,753 Performance Rights issued
(unquoted)

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

Appendix 3B Page 2 04/03/2013
3 Principal terms of the
+
securities
(e.g. if options, exercise price and
expiry date; if partly paid
+
securities, the amount outstanding
and due dates for payment; if
+
convertible securities, the
conversion price and dates for
conversion)

Performance Rights issued under the EBOS
Group Limited Performance Rights Plan.
Vesting of the Performance Rights is subject to
the satisfaction of certain conditions relating to
EBOS Group Limited financial performance
and the continued employment of the holder of
the Performance Rights (Performance
Conditions).
The Performance Conditions will be tested
after the end of the performance period, being 1
July 2019 to 30 June 2022.

There is no amount payable by the Performance
Rights holders either on grant or exercise of the
Performance Rights.

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 3


4 Do the
+
securities rank equally in
all respects from the
+
issue date
with an existing
+
class of quoted
+
securities?

If the additional
+
securities do not
rank equally, please state:
 the date from which they do
 the extent to which they
participate for the next
dividend, (in the case of a trust,
distribution) or interest
payment
 the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
If the Performance Rights vest, the holder will
be entitled to one fully paid ordinary share in
EBOS Group Limited for each Performance
Right or an equivalent amount in cash or a
combination of both (as determined by the
Board). Any fully paid ordinary shares issued
following vesting will rank equally with
existing fully paid ordinary shares.
The Performance Rights have no dividend
entitlement prior to vesting.



5 Issue price or consideration

Nil


6 Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly
identify those assets)






Performance Rights issued under the EBOS
Group Limited Performance Rights Plan.


6a Is the entity an
+
eligible entity that
has obtained security holder
approval under rule 7.1A?

If Yes, complete sections 6b – 6h
in relation to the
+
securities the
subject of this Appendix 3B, and
comply with section 6i
No.


6b The date the security holder
resolution under rule 7.1A was
passed
N/A


6c Number of
+
securities issued
without security holder approval
under rule 7.1
N/A


6d Number of
+
securities issued with
security holder approval under rule
7.1A
N/A

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

Appendix 3B Page 4 04/03/2013
6e Number of
+
securities issued with
security holder approval under rule
7.3, or another specific security
holder approval (specify date of
meeting)

N/A


6f Number of
+
securities issued under
an exception in rule 7.2
N/A


6g If
+
securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+
issue date and both values.
Include the source of the VWAP
calculation.
N/A


6h If
+
securities were issued under
rule 7.1A for non-cash
consideration, state date on which
valuation of consideration was
released to ASX Market
Announcements
N/A


6i Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
N/A


7
+
Issue dates
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule 19.12).
For example, the issue date for a pro rata
entitlement issue must comply with the applicable
timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
9 September 2019



Number
+
Class
8 Number and
+
class of all
+
securities quoted on ASX
(including the
+
securities in section
2 if applicable)



161,708,121 Fully paid ordinary
shares

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 5


Number
+
Class
9 Number and
+
class of all
+
securities not quoted on ASX
(including the
+
securities in section
2 if applicable)



358,803 Performance
Rights (unquoted).


10 Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
N/A


Part 2 - Pro rata issue

11 Is security holder approval
required?

N/A


12 Is the issue renounceable or non-
renounceable?
N/A


13 Ratio in which the
+
securities will
be offered
N/A


14
+
Class of
+
securities to which the
offer relates
N/A


15
+
Record date to determine
entitlements
N/A


16 Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
N/A


17 Policy for deciding entitlements in
relation to fractions

N/A


18 Names of countries in which the
entity has security holders who will
not be sent new offer documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
N/A
19 Closing date for receipt of
acceptances or renunciations
N/A

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

Appendix 3B Page 6 04/03/2013

20 Names of any underwriters


N/A


21 Amount of any underwriting fee or
commission
N/A


22 Names of any brokers to the issue


N/A


23 Fee or commission payable to the
broker to the issue
N/A


24 Amount of any handling fee payable
to brokers who lodge acceptances
or renunciations on behalf of
security holders
N/A


25 If the issue is contingent on security
holders’ approval, the date of the
meeting
N/A


26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
N/A


27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
N/A


28 Date rights trading will begin (if
applicable)
N/A


29 Date rights trading will end (if
applicable)


N/A


30 How do security holders sell their
entitlements in full through a
broker?
N/A


31 How do security holders sell part of
their entitlements through a broker
and accept for the balance?
N/A

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 7

32 How do security holders dispose of
their entitlements (except by sale
through a broker)?
N/A


33
+
Issue date


N/A


Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities

34 Type of
+
securities
(tick one)

(a)

+
Securities described in Part 1


(b)

All other
+
securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee
incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities


Tick to indicate you are providing the information or
documents


35

If the
+
securities are
+
equity securities, the names of the 20 largest holders of the
additional
+
securities, and the number and percentage of additional
+
securities held by
those holders


36

If the
+
securities are
+
equity securities, a distribution schedule of the additional
+
securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over


37

A copy of any trust deed for the additional
+
securities

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

Appendix 3B Page 8 04/03/2013

Entities that have ticked box 34(b)

38 Number of
+
securities for which
+
quotation is sought





39
+
Class of
+
securities for which
quotation is sought




40 Do the
+
securities rank equally in all
respects from the
+
issue date with an
existing
+
class of quoted
+
securities?

If the additional
+
securities do not
rank equally, please state:
 the date from which they do
 the extent to which they
participate for the next dividend,
(in the case of a trust,
distribution) or interest payment
 the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment



41 Reason for request for quotation
now
Example: In the case of restricted securities, end of
restriction period

(if issued upon conversion of
another
+
security, clearly identify
that other
+
security)





Number
+
Class
42 Number and
+
class of all
+
securities
quoted on ASX (including the
+
securities in clause 38)

Appendix 3B
New issue announcement



+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 9


Quotation agreement

1
+
Quotation of our additional
+
securities is in ASX’s absolute discretion. ASX may
quote the
+
securities on any conditions it decides.

2 We warrant the following to ASX.

 The issue of the
+
securities to be quoted complies with the law and is not
for an illegal purpose.

 There is no reason why those
+
securities should not be granted
+
quotation.

 An offer of the
+
securities for sale within 12 months after their issue will
not require disclosure under section 707(3) or section 1012C(6) of the
Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give
this warranty

 Section 724 or section 1016E of the Corporations Act does not apply to any
applications received by us in relation to any
+
securities to be quoted and
that no-one has any right to return any
+
securities to be quoted under
sections 737, 738 or 1016F of the Corporations Act at the time that we
request that the
+
securities be quoted.

 If we are a trust, we warrant that no person has the right to return the
+
securities to be quoted under section 1019B of the Corporations Act at the
time that we request that the
+
securities be quoted.

3 We will indemnify ASX to the fullest extent permitted by law in respect of any
claim, action or expense arising from or connected with any breach of the
warranties in this agreement.

4 We give ASX the information and documents required by this form. If any
information or document is not available now, we will give it to ASX before
+
quotation of the
+
securities begins. We acknowledge that ASX is relying on the
information and documents. We warrant that they are (will be) true and complete.


Sign here: ............................................................ Date: 9 September 2019
(General Counsel)


Print name: Janelle Cain